We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

156 hedge funds and large institutions have $1.6B invested in Chimerix, Inc. in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 70 increasing their positions, 40 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 40

8% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 25

1% more funds holding

Funds holding: 155156 (+1)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

16% less capital invested

Capital invested by funds: $1.89B → $1.6B (-$293M)

19% less call options, than puts

Call options by funds: $4.44M | Put options by funds: $5.48M

Holders
156
Holders Change
+1
Holders Change %
+0.65%
% of All Funds
4.36%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.14%
New
27
Increased
70
Reduced
40
Closed
25
Calls
$4.44M
Puts
$5.48M
Net Calls
-$1.04M
Net Calls Change
-$6.97M
Name Holding Trade Value Shares
Change
Change in
Stake
TCP
26
Tourbillon Capital Partners
New York
$12.8M -$9.37M -189,578 -36%
Loomis, Sayles & Company
27
Loomis, Sayles & Company
Massachusetts
$12.8M +$177K +3,590 +1%
OM
28
Opaleye Management
Massachusetts
$11.8M -$6.42M -130,000 -30%
BM
29
Bridger Management
New York
$11.8M +$15.2M +307,782 New
Millennium Management
30
Millennium Management
New York
$11M +$5.59M +113,181 +65%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$10.8M +$395K +8,000 +3%
Deutsche Bank
32
Deutsche Bank
Germany
$10.7M +$6.7M +135,604 +94%
Norges Bank
33
Norges Bank
Norway
$8.69M +$969K +19,619 +9%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$8.55M -$755K -15,284 -6%
BIA
35
Biondo Investment Advisors
Pennsylvania
$8.53M +$47K +952 +0.4%
CWG
36
C WorldWide Group
Denmark
$8.48M -$2.57M -52,050 -19%
Asset Management One
37
Asset Management One
Japan
$7.7M -$2.72M -55,002 -21%
Axa
38
Axa
France
$7.64M -$209K -4,228 -2%
EA
39
Emerald Advisers
Pennsylvania
$6.59M +$184K +3,734 +2%
EMFAT
40
Emerald Mutual Fund Advisers Trust
Pennsylvania
$6.53M +$1.82M +36,880 +28%
TCIM
41
TIAA CREF Investment Management
New York
$6.08M +$904K +18,290 +13%
BIM
42
BlackRock Investment Management
Delaware
$5.82M +$621K +12,566 +9%
GC
43
Guggenheim Capital
Illinois
$5.76M -$315K -6,379 -4%
Charles Schwab
44
Charles Schwab
California
$5.13M +$880K +17,809 +15%
BBA
45
Baker Bros. Advisors
New York
$4.4M
Invesco
46
Invesco
Georgia
$4.28M +$3.71M +75,056 +203%
Connor, Clark & Lunn Investment Management (CC&L)
47
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.28M -$450K -9,100 -8%
Bank of America
48
Bank of America
North Carolina
$3.82M +$3.57M +72,191 +260%
Fidelity International
49
Fidelity International
Bermuda
$3.69M +$4.77M +96,542 New
Morgan Stanley
50
Morgan Stanley
New York
$3.63M -$601K -12,174 -11%

CMRX Hedge Fund Activity: Q3 2015 in Review

156 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q3 2015, worth a combined $1.6B — down 16% from $1.89B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CMRX positions and 25 closed out — a net gain of 2 holders — while 70 added to existing stakes and 40 trimmed.

The largest buyer was Redmile Group, adding an estimated $18.2M. The largest seller was Aisling Capital, cutting an estimated $14.8M.

  • 156 institutional investors held Chimerix, Inc. (CMRX) as of Q3 2015, up from 155 in Q2 2015.
  • Funds reported $1.6B of Chimerix, Inc. stock for Q3 2015, down 16% quarter-over-quarter.
  • 27 funds opened new Chimerix, Inc. positions in Q3 2015 and 25 closed out, a net change of +2 holders.
  • The largest Chimerix, Inc. buyer in Q3 2015 was Redmile Group, an estimated $18.2M added.
  • The largest Chimerix, Inc. seller in Q3 2015 was Aisling Capital, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2015.